Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians’ Interpretation of a US Food and Drug Administration Workshop

The US Food and Drug Administration convened a workshop to discuss clinical trial design challenges and considerations related to the treatment of nontuberculous mycobacterial pulmonary disease, to include topics such as clinical trial end points, duration, and populations. The clinicians participat...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Chest
Главные авторы: Flume, Patrick A., Griffith, David E., Chalmers, James D., Daley, Charles L., Olivier, Kenneth, O’Donnell, Anne, Aksamit, Timothy, Kasperbauer, Shannon, Leitman, Amy, Winthrop, Kevin L.
Формат: Artigo
Язык:Inglês
Опубликовано: American College of Chest Physicians 2021
Предметы:
Chest Infections: Special Features
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039007/
https://ncbi.nlm.nih.gov/pubmed/32853648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.08.2055
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы